Biogen rises as FDA panel backs Alzheimer's drug, easing safety concerns
Go back to Biogen rises as FDA panel backs Alzheimer's drug, easing safety concerns| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 227.23 +0.16 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.07 | 52 Week High | $333.65 | |||
| Open | $227.23 | 52 Week Low | $223.02 | |||
| Day High | $229.36 | P/E | 29.09 | |||
| Day Low | $225.51 | EPS | $7.81 | |||
| Volume | 839,677 | |||||
